ONCOHELIX
Updated 7 days ago
OncoHelix is the commercial entity of molecular and immunological testing portfolio for two clinical and translational research programs within the University of Calgary: POET (Precision Oncology Experimental Therapeutics); HTL (Hematology Translational Lab); Executive Director Dr. Faisal Khan...
Our mission is to facilitate exceptional clinical-grade molecular and immune profile testing for diagnostic, research, commercial and direct consumer use*.
Also known as: OncoHelix Incorporated